bms.comGlobal Biopharmaceutical Company - Bristol Myers Squibb

Our medicines Our stories Investors Contact us Careers United States Close Icon Americas Argentina Spanish Brazil Portuguese Canada English French Chile Spanish Colombia Spanish Mexico Spanish Peru Spanish United States English Asia Pacific Australia English China Simplified Chinese India English Japan Japanese Korea Korean New Zealand English Singapore English Taiwan Traditional Chinese Thailand English Thai Europe Austria German Belgium English Dutch French Czech Republic Czech Denmark Danish Finland Finnish France French Germany German Greece Greek Hungary Hungarian Ireland English Italy Italian Luxembourg English Netherlands English Dutch Norway Norwegian Poland Polish Portugal Portuguese Romania Romanian Spain Spanish Sweden Swedish Switzerland German French United Kingdom English Middle East Israel Hebrew Saudi Arabia English Arabic Turkey Turkish United Arab Emirates English Arabic Other Other Markets Distributor Markets bmsUScqPageLucene MedicinesCareersPress ReleasesMedical InformationPrevious Page Icon Previous Page Icon Our Medicines Patients & caregivers Next Page Icon Patients & caregivers Our medicines Get help paying for your medicines Patient resources Risk evaluation and mitigation strategies (REMS) QUICK LINKS Immunology patient resources Our position on generic drugs Our position on drug pricing Psoriasis around the world Healthcare providers Next Page Icon Healthcare providers Learn about pre-approval access Learn about post study drug access 340B practice fact sheet QUICK LINKS U.S. medical information Clinical trials Pre-approval access request system Post study drug access request system Researchers Next Page Icon Researchers Areas of focus In the pipeline R&D expert voices Our efforts in STEM Clinical trials & research Independent research The Thomas O. Daniel research incubator and collaboration center QUICK LINKS Perspectives from our head of research Research publications Disclosure commitment Investigator sponsored research portal Areas of interest & competitive research grants Compound & technology requests Data sharing request process Translational medicine Investors Next Page Icon Investors Stock information Financial reporting Analyst coverage Events and presentations Shareholder services Acquisition-related information for Celgene shareholders Investor contacts QUICK LINKS Annual report 2023 Dividend history Stock split history Investment return calculator SEC filings Quarterly results Product sales summary Annual reports archive Annual meeting of shareholders Business development Next Page Icon Business development Our partnerships Why partner with us Areas of interest Business development leadership team Begin a discussion Early innovation at BMS QUICK LINKS Download business development brochure "Golden Ticket" contests News Next Page Icon News Press releases Our stories Medical meetings Media library Media contacts QUICK LINKS Scientific media resources Disease state infographics Corporate publicationsNext Page IconOur company Leadership Global Inclusion & Diversity Responsibility Sustainability at Bristol Myers Squibb Contact us QUICK LINKS Global Patient Week Survivorship Today Our technologies History timeline Worldwide locations The Bristol Myers Squibb Foundation People & Business Resource groups Our commitment to global inclusion and diversity Position on key issues Building a better future: Bristol Myers Squibb 2023 ESG report Read a message from our Board Chair and CEO Science Firsthand: Translating the promise of cell therapy Explore BMS 2024 first quarter financial resultsRead more, including important cautionary statements about forward-looking information. Celebrating Latin America’s women in STEMOur multiple myeloma story: Collaboration drives progressResearching lung cancer treatments to give more patients better outcomesToday & tomorrow: Our enduring commitment in hematologyScientific media resourcesOur scientists are driven by curiosity to pursue the best outcomes possible for patients. Explore our strategic research approaches that allow us to investigate the potential of our early discoveries, no matter the platform or modality. Advancing cell therapy: Shaping our approach today to reach more patients tomorrowBuilding a Better Future: Bristol Myers Squibb 2023 ESG Report View our ESG Report Moving forward. Together. Survivorship Today Explore what it means to live with cancer in a series of conversations with survivors from across the country. Learn moreCareers We’re looking for people who want to change lives. Join us as we transform patients’ lives through science. Learn moreInvestors Learn more about how we strive to produce sustained strong performance and shareholder value. Learn moreLooking for answers? Quick links to helpful resources. Clinical Trial Information for researchers Clinical trials and research are a critical part of bringing new medicines to patients. Learn moreFind a clinical trialMedical Information for healthcare providers Information and resources to assist with caring for patients. Resources for U.S. healthcare providersGlobal medical informationHelp paying for your medicines If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help. Find out howMain navigation Home Patients & caregivers Healthcare providers Researchers Investors NewsResources Our medicines Legal notice Privacy notice Trademarks Forward-looking statement UK-CA slavery and human trafficking statement (PDF) Follow us Careers Our stories Contact us Worldwide locations April 25, 2024 © 2024 Bristol-Myers Squibb...